Upload
andrea-filtri
View
38
Download
3
Tags:
Embed Size (px)
Citation preview
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
IMPORTANT DISCLOSURE FOR U.S. INVESTORS: This document is prepared by Mediobanca Securities, the equity research department of Mediobanca S.p.A. (parent company of Mediobanca Securities USA LLC (“MBUSA”)) and it is distributed in the United States by MBUSA which accepts responsibility for its content. The research analyst(s) named on this report are not registered / qualified as research analysts with Finra. Any US person receiving this document and wishing to effect transactions in any securities discussed herein should do so with MBUSA, not Mediobanca S.p.A.. Please refer to the last pages of this document for important disclaimers.
Unicredit
07 May 2015 Banks Update
Beware the Underdog Andrea Filtri
Equity Analyst
One of Europe’s best ‘value for money’ large caps – €9.1 TP on 2016 rollover
We see UCG as a restructuring story - with cost cutting in Italy well under way
and about to start in Germany and Austria – well positioned to benefit from the
following macro trends: a) ECB QE through peripheral and CEE exposure, b) the
recovery in Eurozone GDP, c) the inversion of the asset quality cycle. We believe
delivery on 2015 results, further RWA optimisation and improved NPL recovery in
Non-Core will fend off the current market worries on capital ratios. We see UCG
on 0.8x 2015E TE for 9% 2016E RoTE, one of the most attractive stories at
discounted valuation. We reiterate our Outperform.
Asset quality and NIM normalization worth 6 p.p. higher RoTE
The Q413 monster cleanup has been effective: NPLs were up 1% in 2014 (19%
Italian banks), while maintaining a high 51% coverage ratio. Internal migration is
ongoing but new NPL formation is negative. This suggests to us 2015 will mark
the turning point and a new cycle is in sight. Both our top-down (44bp LLP and
310bp NIM) and our bottom-up (48bp LLP and 372bp NIM) approaches estimate a
normalization of LLPs and NIM could boost PBT by €3bn and RoTE by 6 p.p., a
30% and 5% premium to MB 2017E and to the 2018 Strategic Plan target.
High gearing to ECB’s QE and to Eurozone economic recovery
We see two strong tides potentially lifting European banks: 1) ECB QE, 2) a
recovery in the GDP of the Eurozone. On the first, as the huge FED balance sheet
expansion propelled US and adjacent Emerging Markets, we believe the ECB‟s QE
program will be a large positive catalyst for CEE exposure. On the second, we
found that the joint industrial production of ITA+GER+AUT is a key factor
determining the Eurozone‟s GDP two quarters later. Finally, we believe that QE
and GDP recovery jointly determine an increase in NPL values from higher
recovery values, lower funding costs and the market‟s hunt for yield. These
could couple with the Italian government‟s efforts to reform the bankruptcy law,
fast forwarding NPL recovery and therefore their NPV. With NPLs/TE at 2x, CEE
at 50% 2015E group PBT and with ITA+GER+AUT at 82% of group loans, we see
UCG ideally positioned to intercept these tidal trades.
1 bank, 1 capital, 1 funding: c.+50% EPS potential, ¼ from Corporate Center
So far Banking Union has only meant costly regulatory hurdles for banks. This is
why the market has overlooked the advantages this should bring - particularly to
cross border banks – from the convergence of national markets into a single one.
We assess the potential impact from the optimisation of capital, liquidity and
group structure following the logic of one market, one company, one capital,
one liquidity pool, similarly to what UCG implemented in Italy in 2010 with
project One4C. We find potential for 48% boost to 2016E EPS: +12% p.p. from
c.4,200 staff cuts in the corporate centre; +26 p.p. from €1.3bn lower pretax
funding costs from realigning the cost of the funding gap to German levels; +10
p.p. from €0.5bn higher pretax from the redeployment of German and Polish
excess capital at the expense of 24bp CET1 gearing. It is admittedly early to
assess the extent to which these potential can be extracted and over what time
period. Yet, the magnitude is such that could mean a reduction of 2016E P/E
from 9.6x to 6.5x and cannot be therefore ignored. Beware the Underdog!
+44 203 0369 571
Antonio Guglielmi
Equity Analyst
+44 203 0369 570
Andres Williams
Equity Analyst
+44 203 0369 577
Source: Mediobanca Securities
Price: € 6.26 Target price: € 9.10 Outperform
2014 2015E 2016E 2017E
EPS Adj (€) 0.37 0.55 0.66 0.86
DPS (€) 0.11 0.19 0.23 0.34
TBVPS (€) 7.30 7.58 7.88 8.35
Avg. RoTE Adj (%) 5.2% 7.4% 8.5% 10.6%
P/E Adj (x) 17.0 11.4 9.5 7.3
Div.Yield(%) 1.8% 3.1% 3.7% 5.5%
P/TBV (x) 0.9 0.8 0.8 0.7
Market Data
Market Cap (€m) 36,211
Shares Out (m) 5,789
(%)
Free Float (%) 100%
52 week range (€) 6.87-4.91
Rel Perf vs STOXX EUROPE 600 (%)
-1m -0.7%
-3m 8.4%
-12m -15.6%
21dd Avg. Vol. 67,924,873
Reuters/Bloomberg CRDI.MI / UCG IM
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 2
Price: € 6.26 Target price: € 9.10 Outperform
Valuation Matrix
Source: Mediobanca Securities
Source: Mediobanca Securities
Profit & Loss Acc(€ m) 2014 2015E 2016E 2017E Multiples 2014 2015E 2016E 2017E
Net Interest Income 12,442 12,769 13,182 14,023 P/E 18.3 12.6 11.4 7.5
Growth (%) 1.1% 2.6% 3.2% 6.4% P/E Adj. 17.0 11.4 9.5 7.3
Non-Interest Income 10,849 11,320 11,931 12,279 P/Net Op.Income 4.4 4.0 3.6 3.3
Growth (%) -7.5% 4.3% 5.4% 2.9% P/Revenues 1.6 1.6 1.5 1.4
of which Fee Income 7,572 7,973 8,297 8,486 P/TBV 0.9 0.8 0.8 0.7
of which Financial Income 1,557 1,642 1,827 1,881 P/Total Deposits (%) 18.5% 16.3% 14.6% 13.3%
Total Income 23,291 24,089 25,113 26,302 Yield (%) 1.8% 3.1% 3.7% 5.5%
Growth (%) -3.1% 3.4% 4.2% 4.7%
Total Costs -14,672 -14,610 -14,732 -14,748
Growth (%) -2.0% -0.4% 0.8% 0.1%
of which Personnel Costs -8,201 -8,137 -8,190 -8,179
Net Operating Income 8,619 9,479 10,381 11,554
Growth (%) -4.9% 10.0% 9.5% 11.3%
Provisions&Write-downs -4,651 -4,376 -4,246 -3,784 Per Share Data (€) 2014 2015E 2016E 2017E
Extraordinary Items -405 -268 -228 -148 EPS 0.34 0.50 0.55 0.83
Pre-tax profit 4,091 5,045 5,496 7,732 EPS growth (%) nm 45.2% 10.4% 52.1%
Tax -1,297 -1,463 -1,594 -2,165 EPS Adj. 0.37 0.55 0.66 0.86
Tax rate(%) 31.7% 29.0% 29.0% 28.0% EPS Adj. growth (%) nm 49.0% 20.7% 30.4%
Minorities and others -380 -336 -386 -419 TBVPS 7.30 7.58 7.88 8.35
Net profit 2,008 2,978 3,288 5,000 DPS Ord 0.11 0.19 0.23 0.34
Growth (%) nm 48.3% 10.4% 52.1%
Adjusted net profit 2,206 3,288 3,970 5,176
Growth (%) nm 49.0% 20.7% 30.4%
Balance Sheet (€ m) 2014 2015E 2016E 2017E Key Figures & Ratios 2014 2015E 2016E 2017E
Customer Loans 470,569 475,124 483,595 495,306 Avg. N° of Shares (m) 6,005 6,005 6,005 6,005
Growth(%) -2.7% 1.0% 1.8% 2.4% EoP N° of Shares (m) na na na na
Customer Deposits 203,183 230,504 257,042 281,536 Avg. Market Cap. (m) 36,003 37,560 37,560 37,560
Growth(%) 15.5% 13.4% 11.5% 9.5%
Shareholders' Funds 49,390 51,217 53,116 56,046 NII/Total Income (%) 53.4% 53.0% 52.5% 53.3%
Minorities 3,446 3,515 3,585 3,657 Fees/Total Income (%) 32.5% 33.1% 33.0% 32.3%
Total Assets 841,054 860,456 882,785 906,682 Trading/Total Income (%) 6.7% 6.8% 7.3% 7.2%
Cost Income ratio 63.0% 60.7% 58.7% 56.1%
Personnel costs/Total costs 55.9% 55.7% 55.6% 55.5%
Impairment/Average Loans 1.0% 0.9% 0.9% 0.8%
NPLs ratio 11.1% 10.5% 9.9% 9.3%
Provisions/Loans 2.3% 2.3% 2.3% 2.3%
Avg. RoTE Adj. (%) 5.2% 7.4% 8.5% 10.6%
ROA (%) 0.24% 0.35% 0.38% 0.56%
Tier 1 ratio 11.3% 11.6% 11.8% 12.6%
Basel III Core Tier 1 ratio 10.0% 10.3% 10.6% 11.4%
4.50
5.00
5.50
6.00
6.50
7.00
7.50
8.00
M J J A S O N D J F M A
Unicredit STOXX EUROPE 600
5/05/15
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 3
Price: € 6.26 Target price: € 9.10 Outperform
Executive Summary Stand alone restructuring and solid positioning on macro trends
We reiterate our Outperform on UCG and raise our Target Price (TP) to €9.1 from the rollover to
2016E, leaving over 40% upside on current prices. We see UCG as a sound restructuring story with
cost cutting in western Europe – Italy is well under way, Germany and Austria are just starting – well
positioned to benefit from the main macro trends ongoing:
1) ECB QE to boost peripheral Eurozone and CEE recovery;
2) The recovery in Eurozone GDP to come mainly from industrial production in Germany, Italy
and Austria;
3) The inversion of the asset quality cycle.
We see UCG on 0.8x 2015E TE for 9% 2016E ROTE, one of the most attractive value for money EU
large caps.
Delivery in 2015 to fend off capital worries
Despite CET1 ratios in line with main European banks, the market remains uncomfortable with
UCG‟s capital adequacy. We believe that accelerating organic capital generation, combined with
further RWA free up from the run-off of the Non-Core and the optimisation of models and the
delivery of the Pioneer-Santander Asset Management deal will take CET1 towards levels of comfort,
triggering the partial removal of the current valuation discount, in our view.
Asset quality and NIM normalisation worth 6 p.p. higher RoTE
UCG launched a monster cleanup in Q413 with €10bn provisions raising NPL coverage by 7 p.p. and
anticipating the AQR and restoring pre-crisis levels. The measure has been effective: despite an
increase of Italian NPLs by 19%, NPLs at UCG grew only 1%, marking the reach of stability. Within
this context, internal migration is ongoing, but formation of new NPLs is already at negative rates.
This suggests to us the turning point is close and a new cycle of asset quality is about to start. We
estimate a normalisation of LLPs and NIM could boost PTP by €3bn and RoTE by 6 p.p. a 30% and 5%
premium to MB 2017E and 2018 Business Plan target. This indicates we are likely at the bottom of
the RoTE potential of the group and that material further upgrades could come from a speeding up
in normalisation and from relevering (excluded from the normalisation exercise), in our view.
Table 1: simulation of UCG LLP trough and corresponding NIM vs UCG estimates
LLP
trough
year
trough
(bp)
LLP
2016e
LLP
2017e
NIM of
LLP
trough
year
NIM
2016
2016
loans
LLP:
2017 vs
trough
NII:
2016 vs
trough
UCG
group
CB / retail 2007 53 46 45 3.78% 2.98% 268,309 215 2,146
CIB 2007 45 40 40 1.91% 2.62% 92,795 46 -659
Poland 2008 12 60 55 6.71% 4.08% 29,371 -126 772
CEE 2007 47 138 123 4.81% 4.41% 60,676 -461 243
Divisional LLP realignment
-326 2,503
2017 RoTE points
0.7% 5.0% 5.6%
Group 2007 44 83 73 3.08% 2.75% 483,595 -1,402 1,596
2017 RoTE points
2.8% 3.2% 6.0%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 4
Price: € 6.26 Target price: € 9.10 Outperform
High gearing into QE in CEE and Eurozone GDP recovery in w-Europe
As the huge FED balance sheet expansion propelled US equities forward but also significantly
benefitted adjacent Emerging Markets (Mexico above all), we believe the ECB‟s QE program could
be a positive catalyst for CEE. Meanwhile, we are seeing a stabilisation of the Russian and Ukrainian
situations limiting downside from that front.
On the macro recovery of the Eurozone, half of the overall industrial production comes from
ITA+GER+AUT, UCG‟s core western European countries. In a regression, we find that their
aggregate industrial production is a key factor determining Eurozone GDP with a lag of two
quarters. In turn, GDP growth is a strong inverse predictor of NPL growth seven quarters later.
With NPLs/TE of 2x, with 50% of the bank‟s 2015E PBT from CEE and with ITA+GER+AUT
representing 82% of group loans, we see UCG very well positioned to intercept the benefits of QE
and of a Eurozone GDP recovery.
Industry and Manufacturing value added vs EMU GDP lagged by 2 quarters, 2006-14
Source: Mediobanca Securities, Eurostat
48% EPS upgrade potential from Banking Union’s one company, one capital, one
liquidity
So far Banking Union has meant costly regulatory hurdles for banks. Progressively, we believe
Banking Union should bring advantages – particularly to cross border names - from the convergence
of national markets into a single one. We assess the potential impact from the optimisation of
capital, liquidity and group structure following the logic of one market, one company, one capital,
one liquidity pool, similarly to what UCG implemented in Italy with project One4C in 2010. We find
potential improvements of up to 48% boost to 2016E EPS from:
c.4,200 staff cuts in the corporate centre: +12% EPS;
€1.3bn lower pretax funding costs from realignment of the funding gap to German levels:
+26% EPS;
€0.5bn higher pretax from the redeployment of German and Polish excess capital, at the
expense of 24bp CET1 gearing: +10% EPS.
It is admittedly early to assess the extent to which these potential can be extracted and over what
time period. Yet, the magnitude is such that could mean an optical reduction of 2016E P/E from
9.6x to 6.5x and cannot be therefore ignored, in our view.
-25%
-20%
-15%
-10%
-5%
0%
5%
10%
15%
20%
1Q
06
2Q
06
3Q
06
4Q
06
1Q
07
2Q
07
3Q
07
4Q
07
1Q
08
2Q
08
3Q
08
4Q
08
1Q
09
2Q
09
3Q
09
4Q
09
1Q
10
2Q
10
3Q
10
4Q
10
1Q
11
2Q
11
3Q
11
4Q
11
1Q
12
2Q
12
3Q
12
4Q
12
1Q
13
2Q
13
3Q
13
4Q
13
1Q
14
EMU GDP
IT+DE+AT Value Added
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 5
Price: € 6.26 Target price: € 9.10 Outperform
EPS and P/E sensitivity from Banking Union potential upside, 2016E
Source: Mediobanca Securities, company data
9.6x
6.5x
.x
2.x
4.x
6.x
8.x
10.x
12.x
0.00
0.20
0.40
0.60
0.80
1.00
1.20
2016E change in structure
Liquidity optimisation
Capital optimisation
Banking Union best case
EPS, €
P/E (rhs)
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 6
Price: € 6.26 Target price: € 9.10 Outperform
Asset quality: 2015 bound to be the turnaround year UCG launched a monster cleanup in Q413 with €10bn provisions raising NPL coverage
by 7 p.p. and anticipating the AQR and restoring pre-crisis levels. The measure has
been effective: despite an increase of Italian NPLs by 19%, NPLs at UCG grew only 1%,
marking the reach of stability. Within this context, internal migration is ongoing, but
formation of new NPLs is already at negative rates. This suggests to us the turning
point is close and a new cycle of asset quality is about to start. We estimate a
normalisation of LLPs and NIM could boost PTP by €3bn and RoTE by 6 p.p. a 30% and
5% premium to MB 2017E and 2018 Business Plan target. This indicates we are likely
at the bottom of the RoTE potential of the group and that material further upgrades
could come from a speeding up in normalisation and from relevering (excluded from
the normalisation exercise), in our view.
Gross impaired loans to tangible equity have stabilized…
Chart 1 shows the evolution of the total gross impaired loans to tangible equity at UCG from 2006 to
2014. This peaked at 196% in Q113, up from 124% in Q406, implying c.10 p.p. increase per annum.
The ratio has stabilised below 190% since the large asset quality cleanup of Q413 and remained
unscathed following the Comprehensive Assessment.
…with NPL vs doubtful and past due dichotomy signaling the turning point of the cycle
Chart 2 shows the evolution of the gross (lhs) and net (rhs) total impaired loans composition from
2006 to 2014. We note:
1) The stabilisation of total impaired loans, with the sharp correction of net impaired loans in
Q413 post cleanup;
2) The sharp reduction in doubtful, past due and restructured loans from their peaks;
3) The stable to slight increase in NPLs.
Chart 1: total gross impaired loans / tangible equity, 2006 – 2014
Source: Mediobanca Securities, company data
124%
196%188%
0%
20%
40%
60%
80%
100%
120%
140%
160%
180%
200%
Q4 06 Q2 07 Q4 07 Q2 08 Q4 08 Q2 09 Q4 09 Q2 10 Q4 10 Q2 11 Q4 11 Q2 12 Q4 12 Q2 13 Q4 13 Q2 14 Q4 14
Self-clean up through reset of EL shortfall
Comprehensive Assessment
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 7
Price: € 6.26 Target price: € 9.10 Outperform
Chart 2: evolution of rebased gross (lhs) and net (rhs) total impaired loans and their composition, 2006 = 100
Source: Mediobanca Securities, company data
In particular, Chart 3 shows the QoQ formation of NPLs, past due and past due + doubtful loans. We
identify three separate periods:
1) 2007-2009: over this period, all categories were growing at an average 7% per quarter,
with past due+doubtful growing at 10% a quarter and reflecting a marked creation of new
bad loans.
2) 2010-2013: this period marked a gradual slowdown in the formation of new bad loans with
all categories growing at an average 2% a quarter and with NPLs growing faster (3%)
suggesting the new formation plus the rating migration trends were well under way.
3) 2014 to date: following UCG‟s Q413 cleanup and despite the release of the Comprehensive
Assessment results in Q314, all categories grew at an average -2% a quarter in 2014, but
with NPLs up 2% a quarter, past due down 6% a quarter and doubtful+past due down 2%.
We believe the above trends reflect the turning point in the asset quality cycle, where internal
credit migration is ongoing (from past due, restructured and doubtful into NPL) but with a reduction
in the flow of new impaired loans (past due, restructured and doubtful).
Chart 3: evolution of QoQ NPL growth by category, %
Source: Mediobanca Securities, company data
Q413 cleanup re-established pre-crisis coverage levels
Chart 4 shows the evolution of cash coverage across the different impaired loan categories from
2006 to 2014. This shows that the Q413 cleanup restored pre-crisis cash coverage levels. In detail,
NPLs stand at 62% coverage, 2 p.p. below Q406, but doubtful and past due loans carry materially
187
402
376
161
128
329
140
206
0
50
100
150
200
250
300
350
400
450
Q4 06
Q2 07
Q4 07
Q2 08
Q4 08
Q2 09
Q4 09
Q2 10
Q4 10
Q2 11
Q4 11
Q2 12
Q4 12
Q2 13
Q4 13
Q2 14
Q4 14
NPLsDoubtfulRestructuredPast dueGross tot. Impaired
203190
350
333
149
309
118
230206
0
50
100
150
200
250
300
350
400
Q4 06
Q2 07
Q4 07
Q2 08
Q4 08
Q2 09
Q4 09
Q2 10
Q4 10
Q2 11
Q4 11
Q2 12
Q4 12
Q2 13
Q4 13
Q2 14
Q4 14
NPLs - net
Doubtful - net
Restructured - net
Past due - net
Net tot. Impaired
-30%
-20%
-10%
0%
10%
20%
30%
Q3 07 Q2 08 Q1 09 Q4 09 Q3 10 Q2 11 Q1 12 Q4 12 Q3 13 Q2 14
Past due + doubtful
Past due
NPLs
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 8
Price: € 6.26 Target price: € 9.10 Outperform
higher cash coverage at 35% and 23%, respectively versus 27% and 9% pre-crisis. Also, the generic
reserve has been bolstered at 0.6% vs 0.4%.
New cycle is in sight: regression of Past due plus doubtful loans vs NPLs
Chart 5 shows the results from the regression of the cumulative flows of past due+doubtful loans vs
NPLs from 2008 to 2014. We note a growing statistical significance and beta multiplier into 2013
and a more sharp decrease of both indicators in 2014. This would suggest that the relationship
between the two variables has tightened every year from 2008 to 2013 and has inverted in 2014.
NPL recoveries three years after the initial deterioration of the asset quality cycle…
Chart 6 shows the r-squared and beta multipliers of the regression of NPLs and past due+doubtful
loans flows (lhs) and of past due only (rhs) of quarterly data from 2007-2014, where NPLs have been
lagged from t0 to t16 to test the inter temporal relationship of past due and doubtful loans with
Chart 4: evolution of coverage ratios, 2006-2014, %
Source: Mediobanca Securities, company data
Chart 5: R-squared and beta of the regression of past due + doubtful loans on NPLs cumulative
flows, 2008-14
Source: Mediobanca Securities, company data
64%
57%62%
27%
33%35%
29%
32%34%
9%15%
23%
51%
45%
51%
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
0%
10%
20%
30%
40%
50%
60%
70%
80%
Q4 06
Q1 07
Q2 07
Q3 07
Q4 07
Q1 08
Q2 08
Q3 08
Q4 08
Q1 09
Q2 09
Q3 09
Q4 09
Q1 10
Q2 10
Q3 10
Q4 10
Q1 11
Q2 11
Q3 11
Q4 11
Q1 12
Q2 12
Q3 12
Q4 12
Q1 13
Q2 13
Q3 13
Q4 13
Q1 14
Q2 14
Q3 14
Q4 14
Performing (rhs) NPL Doubtful loan
Restructured Past due Tot impaired
48.7%
57.0%62.2%
64.8% 65.4% 66.6%62.5%
41%
51%56% 54% 53% 55%
52%
0%
10%
20%
30%
40%
50%
60%
70%
2008 2009 2010 2011 2012 2013 2014
R2 β
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 9
Price: € 6.26 Target price: € 9.10 Outperform
NPLs. The chart on the left shows a high, significant, positive relationship (50%) in the 1st quarter of
recognition of past due+doubtful, followed by three quarters of further weaker positive correlation,
one quarter of rest and 6 following quarters of negative relationship, one quarter of rest and 5
quarters of positive relationship. Imagining a cycle of asset quality deterioration, this suggests that
for the first four quarters there is deterioration across categories (past due, doubtful and NPLs are
growing). After a quarter of reflection, a contraction in past due+doubtful loans still generates NPL
growth, which is then followed by a contraction of both indicators for the following quarters.
Chart 6: regression of NPL and doubtful loans+past due quarterly flows (lhs) and past due only (rhs), 2007-2014
Source: Mediobanca Securities, company data
The chart on the right shows instead very little significance in the flows of past due loans with NPL
creation.
…so that the new NPL cycle is close
Chart 7 shows the QoQ flows of NPLs and past due+doubtful loans from 2012 to 2014. We note that
the two groups have grown hand in hand for the 2012-2013, resembling the 1st phase of Chart 6. In
2014, the latter group have started to fall, while NPLs have continued to grow, marking the second
phase of Chart 6. This trend inversion has been ongoing for circa five quarters, suggesting that the
third phase – i.e. the one of NPL writebacks – should not be far, in our view.
-65%-55%-45%-35%-25%-15%-5%5%15%25%35%45%55%65%
-40%
-20%
0%
20%
40%
60%
t0 t+2 t+4 t+6 t+8 t+10 t+12 t+14 t+16
β R2 (rhs)
0%
2%
4%
6%
8%
10%
12%
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
t0 t+2 t+4 t+6 t+8 t+10 t+12 t+14 t+16
β R2 (rhs)
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 10
Price: € 6.26 Target price: € 9.10 Outperform
UCG has implemented a heavy de-risking strategy from the start of the crisis
Table 2 shows a comparison of the 2015E and 2008 balance sheet, capital, asset quality and P&L
metrics of UCG. We note the following:
18% and 22% total asset and customer loan deleverage;
Capital ratios doubling (10.3% vs 5.3%) from a 29% RWA reduction, taking the density on
loans to 87% from 95%, while tangible equity grew by 60%. This reflects in a leverage ratio
of 5.3% vs 2.7% in 2008;
Asset quality deterioration took gross NPLs / loans to 15.7% from 6.6%, but coverage has
been maintained fairly stable at c.51%;
The P&L reflects the changes with:
19% fall in total revenues;
15% cost contraction;
23% profit fall.
As a result, RoTE of 7.4% is half of the 14% posted in 2008.
Chart 7: Doubtful and past due vs NPL QoQ flows, 2012-2014
Source: Mediobanca Securities, company data
-1,500
-1,000
-500
0
500
1,000
1,500
2,000
2,500
3,000
Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14
Doubtful and past due
NPL
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 11
Price: € 6.26 Target price: € 9.10 Outperform
6 p.p. higher ROTE from LLP and NIM normalization…
Table 3 shows the simulation of the normalization of UCG LLPs and NIM by realigning them to the
LLP trough and to the corresponding NIM of the same year. We run the exercise both bottom-up,
i.e. taking the inputs for each division, and top-down, i.e. taking group figures. Both results point
towards €2.9-3bn PTP boost or c.6 p.p. higher RoTE resulting from the exercise but from a different
split.
If on the one hand, one could argue that today‟s CEE is geopolitically more unstable and risky than
before, on the other the heavy de-risking implemented over the last few years should argue for
lower provisioning levels in a normalised environment.
We note anyhow that the recovery of the LLP and NIM levels of the trough LLP year would restore
UCG‟s 14% RoTE in line with 2008.
Table 2: simulation of UCG LLP trough and corresponding NIM vs UCG estimates
2015 2008 % change delta
Total asset 856,246 1,045,612 -18%
Customer loans 475,124 612,480 -22%
RWA 413,988 584,281 -29%
RWA/loans 87% 95%
-8.3%
Tangible equity (TE) 45,545 28,517 60%
TE/total assets 5.3% 2.7%
2.6%
CET1 ratio 10.3% 5.3%
5.1%
NPL ratio 15.7% 6.6%
9.1%
NPL coverage 50.8% 52.5%
-1.8%
Revenues 24,089 29,671 -19%
(NII+fees)/revenues 86% 96%
-9.9%
Costs -14,610 -17,249 -15%
LLPs 0.87% 0.62%
0.25%
Net profit 3,288 4,256 -23%
RoTE 7.36% 13.7%
-6.32%
Source: Mediobanca Securities, company data
Table 3: simulation of UCG LLP trough and corresponding NIM vs UCG estimates
LLP
trough
year
trough
(bp)
LLP
2016e
LLP
2017e
NIM of
LLP
trough
year
NIM
2016
2016
loans
LLP:
2017 vs
trough
NII:
2016 vs
trough
UCG
group
CB / retail 2007 53 46 45 3.78% 2.98% 268,309 215 2,146
CIB 2007 45 40 40 1.91% 2.62% 92,795 46 -659
Poland 2008 12 60 55 6.71% 4.08% 29,371 -126 772
CEE 2007 47 138 123 4.81% 4.41% 60,676 -461 243
Divisional LLP realignment
-326 2,503
2017 RoTE points
0.7% 5.0% 5.6%
Group 2007 44 83 73 3.08% 2.75% 483,595 -1,402 1,596
2017 RoTE points
2.8% 3.2% 6.0%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 12
Price: € 6.26 Target price: € 9.10 Outperform
…implies 30% and 5% premium to 2017E MB and 2018E BP targets
Table 4 shows the contrast between the 13.7% estimated RoTE at UCG for a normalization of NIM and LLPs vs the 2017E MB estimates and the 2018 UCG Business Plan target. This implies 30% and 5% premium to our 3yr estimates and to the company 2018 BP target, before balance sheet growth is taken into account.
Table 4: RoTE for normalized NIM and LLP vs MB 2017E and 2018 UCG BP target
RoTE Delta vs normalised
Normalised NIM and LLP 13.7%
MB 2017e 10.6% -3.1%
2018 BP target 13.0% -0.7%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 13
Price: € 6.26 Target price: € 9.10 Outperform
Quantitative easing and macro recovery We look at the positioning of UCG on the two main current macro themes: ECB QE and
European macro recovery. The huge FED balance sheet expansion occurred during the
QE program propelled US equities forward but also significantly benefitted adjacent
Emerging Markets. We believe this could be a positive catalyst for CEE during the
ECB’s QE program. Meanwhile, we are seeing a stabilisation of the Russian and
Ukrainian situations limiting downside from that front. On European macro recovery,
ITA+GER+AUT constitute over half of the Eurozone’s industrial production. We plot
the aggregate industrial production of these three core countries and find that this is
a key factor determining GDP with two quarters lag. Finally, we find GDP growth is a
strong inverse predictor of NPL growth seven quarters later. With UCG at NPLs/TE of
2x, with 50% of the bank’s 2015E PBT from CEE and with ITA+GER+AUT representing
82% of group loans, we see UCG very well positioned to capture both the benefits of
QE and of a recovery in Eurozone GDP.
Emerging Markets major beneficiaries of QE proximity Emerging markets equity indices are positively correlated to QE…
Chart 8 shows the evolution of the Federal Reserve‟s balance sheet during its quantitative easing
(QE) program and the evolution of US, Europe and emerging markets‟ (EM) equity indices. We
identify a strong, positive correlation with the US equity index (94% r-squares) confirming the very
large impact of this monetary policy measure on financial markets. Furthermore, we plot the
evolution of EM indices to check the level of influence of QE deriving from the hunt for risk and
yield by developed markets‟ capital. We find an overall strong positive correlation, with
progressively fading impacts differing across geographies:
Mexico is the most correlated emerging market, reflecting its tight relationship with the US
economy;
Asian EM also show a strong positive correlation;
Latin American indices were strongly positively correlated in the earlier phase of QE and
then decorrelated once they started to experience geopolitical turbolence and the Fed
introduced the debate on tapering;
European equities show a statistically insignificant level of correlation and only converge
up once the announcement of a European QE program is expected/made.
Anyhow, we conclude that EM that are closely interlinked with developed markets undergoing a
large QE program strongly benefit from spillovers.
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 14
Price: € 6.26 Target price: € 9.10 Outperform
…suggesting ECB QE should benefit CEE: ½ of group 2015E pretax profits
The above analysis suggests that the ongoing ECB QE program should be largely beneficial for
European emerging markets.
Table 5 shows the pretax profit contribution and the expected 2015-16E GDP growth of the major
eastern European (CEE) countries UCG is active in. we estimate 34% and 48% of the 2015E core and
of the group pretax profits is generated in the region with Poland, Turkey, Russia and Czech making
up for ¾ of the sample. This area is expected to grow at c.2% in 2015E and 3% in 2016E, providing a
growth engine for the UCG group. We expect this area to vastly benefit from the ongoing ECB QE
program, in line with what described in Chart 8.
Russian and Ukrainian situations have partially stabilised
Not all EM can benefit from the ongoing QE program of the ECB. Geopolitical tensions in eastern
Europe remain and the Russian-Ukranian turbulence is not over. Chart 9 shows the evolution of the
FX between the Euro and the Russian and Ukranian currencies from 1/1/2014 to date. This shows
how in 2014, following the breakout of the Crimean war, the Russian Ruble and the Ukranian
Hryvnia devalued by c.50% in 2014. Since then, the Ruble has recovered c.15 p.p., while the
Hryvnia as further slipped by c.10 p.p..
Chart 8: FED balance sheet vs equity US and Emerging Markets indices, 2009-2015
Source: Mediobanca Securities, company data
Table 5: CEE weight into UCG, 2015E
PTP % of UCG % of Core
GDP growth
2015
GDP growth
2016
Poland 835 17% 12% 3.4 3.6
Turkey* 396 8% 6% 3.4 3.8
Russia 338 7% 5% -4.1 0.5
Czech 218 4% 3% 2.4 2.8
Bulgaria 188 4% 3% 1.2 2
Croatia 141 3% 2% 0.3 1
Rest of CEE 283 6% 4%
CEE 2,399 48% 34% 1.7 2.7
Source: Mediobanca Securities, BBG
* equity consolidation of Yapi Kredi
FED BS
ASIA EM
LATAM
MEX
S&P 500
SXXP
0
50
100
150
200
250
300
Mar
-09
Jul-
09
No
v-0
9
Mar
-10
Jul-
10
No
v-1
0
Mar
-11
Jul-
11
No
v-1
1
Mar
-12
Jul-
12
No
v-1
2
Mar
-13
Jul-
13
No
v-1
3
Mar
-14
Jul-
14
No
v-1
4
Mar
-15
FED BS ASIA EM LATAM
MEX S&P 500 SXXP
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 15
Price: € 6.26 Target price: € 9.10 Outperform
Russia and Ukraine: 4-5% of UCG BV and 7-10% of pre-tax profits
Table 6 summarizes UCG‟s exposures in Russia and Ukraine. The currencies‟ devaluations taken in
Q414 have taken the incidence of these two countries to UCG‟s BV to 4%. The slight strengthening
of the RUB in Q115 should entail a revaluation, taking the ratio to c.4.5%. Both subsidiaries hold
large USD loan exposures (2/3 in Russia, ½ in Ukraine). Following our 25% cut in estimates on Q414
FX devaluations, we see c. 7-10% of UCG‟s pretax profit coming from the region. Yet, on Russia, we
are gaining more comfort at this stage, given the high exposure to mid-sized, export driven
corporates (79% of loans), the large dollar exposure, the solid NPL ratio (3.7%) and the limited net
intragroup exposure (€0.9bn).
Chart 9: EURRUB and EURUAH rebased to 1/1/2014
Source: Mediobanca Securities, BBG
Table 6: summary of UCG’s Russian and Ukranian exposure
Russia % of UCG Ukraine % of UCG
BV (EUR) Q414 1,933 3.9% 75 0.2%
BV (EUR) Q414 @ Q115 FX 2,279 4.6% 58 0.1%
USD denominated assets 66%
70%
2014 PBT (EUR) 448 11% -240 -6%
2015e PBT (EUR) 338 7%
2015e / 2014 PBT -25%
RWAs 15,690 4% 3,200 1%
Corporate loans/ Total loans 79%
45%
NPL ratio 3.7%
c.60%
Net intragroup exposure, Eur bn 0.9
1.0
Source: Mediobanca Securities, company data
54
73
30
45
0
20
40
60
80
100
120
EURRUB
EURUAH
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 16
Price: € 6.26 Target price: € 9.10 Outperform
Industrial production to drive Eurozone’s economic recovery
GER+ITA+AUT industrial production drives west-EU GDP...
Chart 10 shows the share of Eurozone industrial production from Germany, Italy and Austria, UCG‟s
reference countries in western Europe. These three countries represent one half of the entire
industrial production of the area. This contribution has remained fairly stable throughout the last
years, with Italy losing 2 p.p. and Germany and Austria gaining them.
Chart 11 shows the Eurozone‟s Industry and Manufacturing Value Added in Germany, Italy and
Austria, plotted against GDP growth lagged by two quarters. We note a tight, positive relationship
between the two variables, suggesting that manufacturing in these three countries is a significant
factor determining the GDP growth in the Eurozone.
Chart 10: contribution to Eurozone industrial production, 2005-13, %
Source: Mediobanca Securities, Eurostat
Chart 11: Industry and Manufacturing value added vs EMU GDP lagged by 2 quarters, 2006-14
Source: Mediobanca Securities, Eurostat
20% 20% 20% 20% 19% 19% 18% 18% 18%
32% 32% 32% 32% 32% 32% 33% 33% 34%
3% 3% 3% 3% 3% 3% 3% 3% 4%
0%
10%
20%
30%
40%
50%
60%
2005 2006 2007 2008 2009 2010 2011 2012 2013
Austria Germany Italy
-25%
-20%
-15%
-10%
-5%
0%
5%
10%
15%
20%
1Q
06
2Q
06
3Q
06
4Q
06
1Q
07
2Q
07
3Q
07
4Q
07
1Q
08
2Q
08
3Q
08
4Q
08
1Q
09
2Q
09
3Q
09
4Q
09
1Q
10
2Q
10
3Q
10
4Q
10
1Q
11
2Q
11
3Q
11
4Q
11
1Q
12
2Q
12
3Q
12
4Q
12
1Q
13
2Q
13
3Q
13
4Q
13
1Q
14
EMU GDP
IT+DE+AT Value Added
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 17
Price: € 6.26 Target price: € 9.10 Outperform
The impression above is confirmed by Chart 12 which shows the regression of the Eurozone‟s GDP
growth with Industry and Manufacturing Value Added in Germany, Italy and Austria. Dispersion is
fairly limited, reflecting in an r-squared of 50%.
NPL recoveries to follow
Real GDP growth driving NPL recoveries with a 7 quarters lag
Chart 13 shows the regression of Italian GDP growth vs the NPL growth lagged by seven quarters.
The 55% r-squared confirms that NPLs respond to GDP growth with an almost two year lag. This is
fairly consistent with the analysis made on UCG‟s credit cycle in Chart 6 and Chart 7.
Chart 12: regression of EMU GDP on Industry and manufacturing value added (GER+IT+AUT)
Source: Mediobanca Securities, Eurostat
Chart 13: regression of Italian NPL growth t+7 vs real GDP growth, 1998-2014
Source: Mediobanca Securities, Bank of Italy, BBG
R² = 0.5006
7,800
8,000
8,200
8,400
8,600
8,800
9,000
9,200
9,400
9,600
9,800
1,450 1,500 1,550 1,600 1,650 1,700 1,750 1,800 1,850 1,900
EM
U G
DP
Industry and manufacturing value added (IT+GER+AUT)
R² = 0.5473
-30%
-20%
-10%
0%
10%
20%
30%
40%
50%
60%
-8.0% -6.0% -4.0% -2.0% 0.0% 2.0% 4.0% 6.0%
YoY NPL growth t+7
Real GDP YoY growth
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 18
Price: € 6.26 Target price: € 9.10 Outperform
NPLs at 2x tangible equity: UCG is very geared to macro improvements
Table 7 shows the weight of the Non-Core unit as a percentage of UCG group. This attracts 9% of
group loans, 10% of group RWAs, 2/3 of group NPL. UCG is largely exposed to improvements in the
macro scenario given NPLs/TE stand at a very high 192%.
UCG is well positioned to capture Europe’s upswing
In conclusion, we see UCG well positioned to capture an upswing in Europe from:
An industrial production-driven economic recovery in western Europe;
The natural inflation mechanism of Emerging Markets adjacent to developed markets
undergoing QE programs;
The beneficial impact to NPL recovery that economic recovery and QE should bring.
Table 7: Non-core weight as % of group, 2014
Non core
% of group net loans 9%
% of group RWAs 10%
NPLs/ Group NPLs 67%
Group NPLs/TE 192%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 19
Price: € 6.26 Target price: € 9.10 Outperform
A (free) call option on Banking Union’s opportunities So far Banking Union has meant higher regulatory hurdles for banks. Progressively, as
this is implemented, we believe Banking Union should bring advantages – particularly
to cross border names - from the convergence of national markets into a single one.
We assess the potential impact from optimisation from full fungibility of capital and
liquidity and rethinking of group structure following the logic of one company, one
capital, one liquidity pool, similar to what project One4C was for the presence of the
bank in Italy. Our analysis of the corporate centres in Italy, Germany, Austria and
Poland highlight wide asymmetry in efficiency with Germany lagging behind. A
realignment to internal best practice would entail c.4,200 staff cuts for 11-12% EPS
boost. Similarly, the optimisation of funding costs would lead to €1.3bn cost savings or
26% EPS upgrade. Finally, the optimisation of capital allocation would provide further
10% EPS upgrade at the expense of 0-24bp CET1 gearing.
Banking Union to remove the banks-sovereign contagion
Banking Union has been the compromise found by Eurozone partners to reduce the negative
contagion of sovereign and financial sector while leaving the Eurobond or full political union out of
the political agenda. This followed the summer and the fall of 2011 when markets tested the
stability of the Euro by taking sovereign spreads within the Eurozone to unsustainable levels,
demanding a policy intervention. In previous years, national banking regulators had progressively
introduced barriers to the free movement of capital by requiring local subsidiaries of international
group to downstream capital and liquidity at the local level. This imposed high gearing to the
parent companies of multinational groups and the introduction of „diseconomies of scale‟ for banks
operating across national borders, generally defined as Balkanisation.
To react to the markets‟ dislocation, the ECB‟s Governor Draghi introduced the Outrights Monetary
Transactions (OMT) – an unlimited sovereign bond buying program on bonds up to three year
maturity to defend the Currency Union – and governments followed almost a year later with the
Banking Union project, which was based on:
1) A common regulator – the ECB – to take control of the largest banks in the Union following
a Comprehensive Assessment on the asset quality and on the conditions of banks‟ capital
under stress;
2) The institution of a Resolution Fund with ability to recapitalize banks, following the
application of bail-in rules involving at least 8% of liabilities;
3) The progressive mutualisation of national deposit guarantee funds into a single fund for the
Union.
The Single Supervisory Mechanism (SSM) started in November 2014 with the publication of the
results of the Comprehensive Assessment and the implementation of Banking Union is under way.
Banking Union’s costs are a fact of life (sunk costs)...
So far, Banking Union involves extra costs for banks including Resolution Funds and the Deposit
Guarantee Funds. These are intrinsic in holding a banking licence and gathering deposits and hence
we should consider these organic to the mere investment in the sector. Intellectually, it would be
interesting to assess to what extent the introduction of such safety measures could compensate the
higher regulatory costs through a reduction in funding costs and cost of equity. But this is not what
we are concerned about; we take such developments as a fact of life and the logic consequence of
the recent financial crisis.
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 20
Price: € 6.26 Target price: € 9.10 Outperform
...but progressive harmonisation and convergence within the Eurozone...
As the aim of the Banking Union is to cushion and absorb sovereign shocks and asymmetries avoiding
the reciprocal contagion between sovereigns and banks, we should expect a successful
implementation to progressively reduce or remove differences across banks deriving from their
domicile. Hence banks‟ funding costs should more and more reflect their individual credit rating
depending on their business mix and risk profile instead of their geographical operations. It is likely
that within a Banking Union with harmonized rules, banks would more and more look at diversifying
their geographical portfolio through cross border M&A. This should create larger banks where the
relevance of each individual country within the group gets diluted vis-à-vis today. This is likely the
ECB‟s ultimate goal and we would expect the new regulator will favour a consolidation process once
it has gained confidence on the solidity and stability of the current system. Hence, widespread
cross-border consolidation is probably still far, but groups which already operate according to this
setup should start benefitting sooner rather than later, in our view.
...could bring advantages the market has not assessed yet
We are interested to investigate the potential benefits of Banking Union which have not been
assessed – and therefore priced – by the market thus far. We do this knowing that the Banking Union
is a „work in progress‟ new regime and that those who run it could not have made up their minds
regarding all aspects of it.
This should create a single banking market inside the Eurozone, regulated by a single institution and
operating according to a single, harmonized rulebook for all players. Ultimately, this should
progressively bring convergence across banks and geographies, leaving individual banks‟ credit risk
as the main factor dictating funding cost differences.
Meanwhile, we UCG potentially benefitting from the following factors:
Capital and liquidity fungibility;
Rethinking group structure;
Rationalisation of regulatory costs.
UCG is one of the Eurozone’s main banking players
Chart 14 shows UCG‟s geographical positioning in Europe. The group is active with local banking
operations in 17 countries. Eight of these – representing 50% of the Eurozone‟s nominal GDP – belong
to the Eurozone as the group operates in the Baltic countries through its leasing company. This
makes UCG one of the Eurozone‟s largest banks.
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 21
Price: € 6.26 Target price: € 9.10 Outperform
Digging into UCG legal entities to pinpoint upside potential
2010 One4C: seven Italian banks into one and 6% headcount reduction
In 2010, following the acquisition of Capitalia, UCG approved the merger of all Italian subsidiaries
into the parent company Unicredit Spa under the name of the One4C project. This turned the
holding company of the group into an operating company concentrating all Italian banking
operations (UniCredit Banca S.p.A., Unicredit Banca di Roma S.p.A., Banco di Sicilia S.p.A.,
Unicredit Corporate Banking S.p.A., Unicredit Private Banking S.p.A., Unicredit Family Financing
Bank S.p.A. and Unicredit Bancassurance Management & Administration S.c.r.l.) into a single entity
(UniCredit S.p.A.), realigning Italy to the organization of the rest of the group, i.e. with one legal
entity in each country.
UCG provided little disclosure on cost savings from the project, but contemporaneously announced
a headcount reduction plan for 2,575 staff (-6% on the Italian operations).
Chart 14: UCG geographical presence
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 22
Price: € 6.26 Target price: € 9.10 Outperform
One company, one capital, one liquidity pool for the Banking Union
We believe the Banking Union could trigger a similar operation to One4C at UCG, this time
implemented cross border for the regions belonging to the Banking Union. Our vision is a single
company maximizing economies of scale and scope, getting rid of national and central functions
duplications and allocating capital liquidity in the profit maximizing way subject to doing so within
the geographies of the Union. We are conscious this could be utopistic or premature to say the
least, but this is the logical direction the Banking Union should develop towards.
A change of group structure is a very complex operation...
Conceiving a change of group structure can be a cumbersome and expensive process, involving very
complex items such as:
Fiscal implications – the risk of loss of tax loss carry forward accumulated at national level
(c.€0.3bn remaining);
Taxation – the complex fiscal implications of the operation;
Regulatory Constraints – these operations particularly involve local regulatory constraints
which the Banking Union should overcome;
Political constraints – reducing visibility, staff, headquarters and potentially local taxation
can have sensitive political implications which can affect these operations;
Legal constraints – the shift could clash with previous legal constraints. For instance, we
recall the 2005 business combination agreement of the UCG-HVB-BaCa merger included a
clause locking for 10 years the running of CEE operations from Austria;
Market perception – the risk that the benefits from the lower funding costs for
geographies with higher sovereign spreads would be offset by a contamination of the
funding costs of high-rated geographies.
Chart 15: Unicredit group structure
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 23
Price: € 6.26 Target price: € 9.10 Outperform
...but here we just focus on the potential opportunities
In this note, we acknowledge the potential difficulties of a potential change in group structure, but
assume these are issues which can be overcome and focus on the potential opportunities this
change could bring.
Geographical visibility on Corporate Centre shows wide asymmetries in efficiency...
Table 8 shows our reconstruction of the geographical composition of UCG‟s corporate centre (C.C.).
We started from the group‟s C.C., we dug out the figures of the corporate centers belonging to
Austria, Germany and Poland and have calculated the Italian/Group Central Functions of the group
corporate center by difference. We note the following:
12% of UCG group staff work in local and group corporate centres. C.C. hold 12% of group
RWAs and represents 9% of group costs, 17% of group pre-provision profits and 30% of
group PBT;
Corporate centers are very different within the same group, they service different type of
activities, yet some differences are hard to understand at a first glance and could be
hiding some room for higher efficiency if scale economies can be exploited through the
removal of national constraints;
45% of the Corporate Centre staff service Italian operations and the group central
functions, in line with their share of Corporate Centre RWAs of 48%. These employees
service 47% of group loans, 42% of RWAs (higher than average mortgage exposure) and 30%
of group costs;
41% of C.C. staff stand in Germany vis-à-vis 24% of C.C. RWAs. Yet, these employees only
service 23% of group loans, 21% of group RWAs and 24% of group costs;
14% of C.C. staff stand in Austria vis-à-vis 27% of C.C. RWAs. These employees service 24%
of group loans, 31% of RWAs and 23% of costs.
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 24
Price: € 6.26 Target price: € 9.10 Outperform
…with most scope for improvements in Germany
From the above we can derive the following initial indications:
There could be relative excess staff in the German Corporate Centre;
The Italian C.C. has potentially higher efficiency than seen as: 1) this likely also
consolidates the staff belonging to Polish operations which are not disclosed in Pekao‟s
annual report and 2) this includes all staff belonging to group central functions;
The Austrian/CEE C.C. shows high efficiency as with only 14% of C.C. staff (i.e. almost 1/3
of the German C.C.) services large operations.
The German C.C. shows potentially low levels of efficiency as: 1) holds the same
employees of the Italian and group central functions C.C. but servicing half of the
loans/RWAs. German C.C. looks overstaffed also when looking at ratios like staff/RWA
serviced or staff/loans serviced where the German C.C. emerges at 1.7x and 2x the
average of the group C.C. German staff also results 20% more expensive than the average
Table 8: Corporate centre geographical composition
Group C.C. C.C. AUT/CEE C.C. GER C.C. Pekao
C.C. Italy +
group H.Q.
Revenues -1,014 -122 197 120 -1,171
Costs -800 -235 -151 0 -414
...Staff -1,177 0 -582 0 -595
Operating income -1,814 -357 46 120 -1,585
PTP -1,789 -320 180 120 -1,769
Net customer loans -6,440 0 -1,123 0 -5,317
RWAs 50,194 13,385 12,286 274 24,250
Deposits from customers 1,587 0 0 0 1,587
Bonds 61,717 0 0 0 61,717
Employees 15,793 2172 6,531 n.a. 7,090
Loans serviced 475,124 113732 109,636 26,729 225,027
RWA serviced 409,223 125081 85,768 27,710 170,664
Costs serviced 14,672 3336 3,559 3,426 4,351
Costs serviced/staff, € m 0.93 1.54 0.54 n.a. 0.61
Staff cost/staff, € -74,506 0 -89,113 n.a. -83,875
Costs/Staff, € -50,670 -108,195 -23,121 n.a. -58,402
Costs as % of group C.C. 100% 29% 19% 0% 52%
Costs/loans, € -1,684 -2,066 -1,377 -6 -1,840
Costs/RWAs, € -1,956 -1,879 -1,761 -6 -2,426
serviced RWA/loans 86% 110% 78% 104% 76%
Staff/loans serviced 0.03 0.02 0.06 n.a. 0.03
Staff/RWAs 0.31 0.16 0.53 n.a. 0.29
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 25
Price: € 6.26 Target price: € 9.10 Outperform
cost of group C.C. staff. Yet, overall costs are low at the German C.C. as likely recoveries
on services provided (G&A) compensate for staff cost.
11-12% EPS upgrade from Corporate Centre rationalisation
The previous paragraphs have showed that there is room for efficiency enhancements inside UCG‟s
corporate centres. Whether this depends on a unification of operations within the Banking Union or
on the optimisation of resources is beyond us. Yet, Table 9 simulates the realignment of staff
allocation to the German C.C. in line with internal best practice according to two ratios:
1) Staff / loans serviced
2) Costs serviced / staff
Both methodologies point towards c. 4200-4400 headcount reductions, implying 27-28% reduction to
the overall C.C. staff and 2/3 reduction in Germany. These should generate between €376-395m
cost savings, implying almost halving C.C. costs at UCG. These savings would entail 11-12% 2016E
EPS upgrade at UCG.
This simulation expresses by no means the cost cutting potential from the merger of banking
operations in the Banking Union, but provides a ball park figure of how significant cost savings could
be, in our view.
Chart 16: C.C. distribution of RWA (lhs) and staff (rhs), UCG 2014
Source: Mediobanca Securities, company data
27%
14%
24%31%
23%
24%
41% 23%
21%
24%
6%
7%23%
48% 45% 47%42%
30%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
RWAs Employees Loans serviced RWA serviced Costs serviced
C.C. Italy + group H.Q. C.C. Pekao C.C. GER C.C. AUT/CEE
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 26
Price: € 6.26 Target price: € 9.10 Outperform
26% EPS upgrade from funding cost savings
Funding composition across legal entities
Table 10 shows the current asymmetry in funding costs split by deposit rates, bond rates, interbank
deposits and financial liabilities held for trading across UCG‟s HVB, Bank Austria, Pekao and Parent
company. These are contrasted with the respective lending rates. We note the following:
Table 9: Simulation of C.C. rationalization according to internal best practice, 2014
Group
C.C.
C.C.
AUT/CEE C.C. GER
C.C.
Pekao
C.C. Italy +
group H.Q.
As % of
group C.C.
Savings as % of
group C.C.
As % of 2016E EPS
after 30% tax rate
Costs -800 -235 -151 0 -414
Net customer loans -6,440 0 -1,123 0 -5,317
Employees 15,793 2,172 6,531 0 7,090
Costs serviced -14,672 -3,336 -3,559 -3,426 -4,351
Loans serviced 475,124 113,732 109,636 26,729 225,027
Staff/loans serviced 0.03 0.02 0.06 0.03
Costs serviced/staff, € m -0.93 -1.54 -0.54 -0.61
Stuff cuts from realigning
staff/ loans -4,437 -28%
Cost Savings 395 -49% 12%
Staff cuts from realigning to cost serviced/staff -4,214 -27%
Cost Savings 376 -47% 11%
Source: Mediobanca Securities, company data
Table 10: Funding cost and lending rate breakdown across UCG’s legal entities, 2014
IT (Spa) ex Non-
Core HVB BACA Pekao Group
Interest income
...loans to customers 6,219 3,480 4,531 4,997 19,227
Interest expense
...deposits from customers -585 -574 -1,202 -1,516 -3,878
...deposits from central banks and banks -256 -466 -25 -747
...debt securities in issue -2,145 -1,797 -781 -94 -4,817
...financial liabilities held for trading -18 -467 -129 -614
Deposit rates -0.35% -0.37% -1.18% -1.21% -0.94%
Bond rates -4.09% -1.55% -2.60% -2.44% -3.21%
Interbank deposits -0.81% -1.97% -0.46% -0.70%
Financial liabilities held for trading -0.14% -13.52% -2.57% -4.04%
Funding costs -0.92% -1.83% -1.26% -1.47%
Lending rates 3.48% 3.17% 3.98% 4.47% 4.09%
RWA/Loans 80% 78% 110% 104% 86%
pretax RoRWA 3.3% 1.3% 1.4% 2.9% 1.0%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 27
Price: € 6.26 Target price: € 9.10 Outperform
Unsurprisingly, BaCa and Pekao remunerate deposits 3x more than HVB and the parent co.
given their large CEE exposure. This also reflects into higher lending rates at 4% and 4.5%,
respectively;
It is surprising to see instead how the parent co. remunerates deposits in line with
Germany‟s HVB. This is not the case for bonds (4.09% vs 1.55%), but as the former
consolidates also group subordinated debt, the comparison is very difficult. Lending rates
instead are fairly similar at 3.5% at the parent co. and 3.2% at HVB;
Chart 17 shows the distribution of the main funding and lending metrics at the main legal entities:
The Parent company, operating Italian banking activities and group holding operations
generates 32% of group interest income, 30% of interest expense, consolidates 41% of
customer deposits, 76% of bonds, 30% of interbank funding, 47% of customer loans and 88%
of funding shortfall (loans – deposits);
HVB, running German banking and group investment banking operations, generates 18% of
group interest income, 24% of interest expense and consolidates 25% of customer deposits,
19% of bonds, 51% of interbank funding, 23% of customer loans and 15% of funding
shortfall;
Bank Austria (BaCa), running Austrian and CEE banking, generates 24% of group interest
income, 29% of interest expense, 25% of customer deposits, 20% of bonds, 22% of
interbank funding, 24% of customer loans and 19% of funding shortfall;
Pekao, running Polish banking, generates 26% of interest income, 18% of interest expense
and consolidates 17% of customer depsoits, 1% of bonds, 1% of interbank funding, 6% of
customer loans and is the only unit without a deposit shortfall.
Chart 17: distribution of funding and lending metrics across legal entities, 2014
Source: Mediobanca Securities, companies
30% 32%41%
76%
30%
47%
88%
24% 18%
25%
19%
51%
23%
15%
29%
24%
25%
20%22%
24%
19%18%
26%
17%1% 1%
6%
-5%
-20%
0%
20%
40%
60%
80%
100%
Interest expense Interest income Deposits from customers
Bonds Interbank funding Customer loans Funding shortfall
Pekao BACA HVB IT (Spa) ex Non-Core
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 28
Price: € 6.26 Target price: € 9.10 Outperform
The chart highlights the following:
The parent company is issuing the majority of bonds, matching the funding shortfall;
HVB is responsible for the majority of interbank funding, likely to fund short term
derivatives books in the investment bank;
The parent co. is pretty balanced in its contribution to interest income and interest
expense. Instead, HVB and BaCa show interest income 6 and 5 p.p. short of their share of
interest expense, while conversely, Pekao has a surplus of 8 p.p.;
Funding cost optimisation worth 26% EPS upgrade
Table 11 simulates the downward repricing of funding shortfall to the internal best practice to
assess the potential funding costs at UCG from an integration of banking operations triggered by
Banking Union. We estimate €70bn deposit shortfall at group level split across the four legal entities
and the majority of which sitting in the parent co.. Given the large asymmetries in bond rates, we
hypothesise the issuance of bonds all from HVB – the price leader. We estimate the current €2.4bn
cost of those funds would drop dramatically to €1bn, for €1.3bn funding cost savings. These, taxed
at 35% would boost 2016E EPS by 26%. Again we see this exercise as a pretty theoretical one; yet
this provides an idea of the magnitude of potential optimisations available to the current group
structure in light of the Banking Union developments.
Table 11: simulation of funding cost savings
IT (Spa) HVB BACA Pekao Group
Deposits from customers 167,990 100,674 102,271 30,012 410,412
Bonds 114,109 28,249 30,014 922 150,276
Interbank funding 31,703 54,080 23,696 1,277 106,037
Customer loans 220,649 109,636 113,732 26,729 470,569
Excess funding -52,659 -8,962 -11,461 3,282 -69,800
Bonds 114,109 28,249 30,014 922 173,294
Share of bonds issued 66% 16% 17% 1%
Current bond rates -4.09% -1.55% -2.60% -2.44%
Current interest expense 1,882 176 315 9 2,381
Optimised interest expense 1,079 1,079
Funding cost savings 1,302
2016E EPS impact @35% Italian tax rate 26%
Source: Mediobanca Securities
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 29
Price: € 6.26 Target price: € 9.10 Outperform
10% EPS upgrade from optimisation of capital allocation
Germany and Poland overcapitalised, gearing in the parent co.
Chart 18 shows the capital ratio and the excess/deficit (vs a national benchmark) across UCG‟s main
legal entities in 2014. This highlights:
HVB and Pekao hold the majority of the group capital with CET1 ratios of 22% and 17%,
respectively and with €15bn estimated excess capital (assuming 11% and 12% min.
requirements, respectively);
The Austrian and CEE operations work with a relatively more geared balance sheet with
10.3% CET1 ratio, in line with the group‟s ratio;
The 21% CET1 ratio reported by the Parent co. incorporates the value of the stakes in the
subsidiaries, implying that the cash component is thinner and is likely where the gearing of
the group lays into.
This very asymmetric distribution of capital derives from the balkanisation occurred during the
crisis where local regulators demanded down streaming of capital and liquidity at local level to ring
fence local banking from the risk of large group defaults.
Chart 18: geographical asymmetry in CET1 ratio and excess capital allocation, 2014
Source: Mediobanca Securities, company data
Up to 10% EPS upgrade from optimisation of capital allocation
Banking Union should remove the local constraints introduced during the crisis. We doubt the ECB
could argue in favour of any particular geographical distribution of capital within cross border banks
operating within the Banking Union. Hence, Table 12 shows the simulation of capital optimisation at
UCG. We assume that excess capital is deployed on the national 10yr sovereign. This implies that
the €9.5bn of German bunds at HVB would only return €7m revenues, or that the €6bn Polish bonds
at Pekao generate €142m. We make two simulations:
1) The redeployment of German excess capital on the higher-returning Italian BTPs;
2) The redeployment of excess capital at the higher ROTE adj. for RWA density (pretax
RoRWAs/RWA density of loans).
21.0%22.1%
10.3%
17.3%
10.4%
0%
5%
10%
15%
20%
25%
-4000
-2000
0
2000
4000
6000
8000
10000
12000
IT (Spa) HVB BACA Pekao UCG Group
Eur mExcess/deficit CET1 ratio (rhs)
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 30
Price: € 6.26 Target price: € 9.10 Outperform
In the first case, we obtain €127m additional PBT, for 3% 2016E EPS boost. In the latter case, we
obtain €493m additional PBT, for 10% 2016E EPS boost, while generating €10bn additional RWAs or
24bp CET1 deduction.
This exercise just points out the potential upside that an optimisation of capital allocation could
bring at UCG for a Banking Union‟s removal of national barriers, in our view.
Table 12: simulation of capital optimisation
IT (Spa) HVB BACA Pekao UCG Group
CET1 ratio (rhs) 21.0% 22.1% 10.3% 17.3% 10.4%
RWAs 206,405 85,768 125,081 115,975 409,223
Min requirement 10.0% 11.0% 12.0% 12.0% 10.0%
Excess/deficit 9,559 -2,126 6,147 1,673
Yield on 10yr govies 1.4% 0.1% 0.2% 2.3%
Current yield on capital excess 7 -4 142 145
Reallocation of investment of excess
capital to BTP 134 134
Additional pretax profits from
redeployment 127 127
2016E EPS impact @35% Italian tax
rate 3%
Loan yields 3.48% 3.17% 3.98% 4.47% 4.09%
Pretax RoTE adj. RWA density 4.09% 1.61% 1.29% 2.79% 1.16%
Excess capital redeployment to avg.
loan yield 111
Excess capital redeployment to max
loan yield 391 -4 251 638
Additional pretax profits from
redeployment 384 0 109 493
2016E EPS impact @35% Italian tax
rate 10%
Additional RWAs created 7,519 2,144 9,663
Impact to CET1 ratio 2014 -0.19% -0.05% -0.24%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 31
Price: € 6.26 Target price: € 9.10 Outperform
Banking Union implementation can become a catalyst to unleash EPS upside
Chart 19 shows the joint effect we estimated from the potential optimisation of group structure,
capital and funding costs the implementation of the Banking Union could potentially bring for UCG.
Our €0.66 2016E adj. EPS would inflate by 48% to €0.98, ½ from lower funding costs, ¼ from lower
corporate centre costs, ¼ from capital optimisation. In turn, this would entail a P/E drop from 9.6x
to 6.5x. Hence, despite having very little visibility on how and when this potential upside could
materialise, the magnitude is such that we cannot ignore it.
Chart 19: EPS and P/E sensitivity from Banking Union potential upside, 2016E
Source: Mediobanca Securities, company data
9.6x
6.5x
.x
2.x
4.x
6.x
8.x
10.x
12.x
0.00
0.20
0.40
0.60
0.80
1.00
1.20
2016E change in structure
Liquidity optimisation
Capital optimisation
Banking Union best case
y x
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 32
Price: € 6.26 Target price: € 9.10 Outperform
Outperform, TP hike to €9.1 from 2016 rollover We roll over the valuation to 2016 and retrieve €9.1 Target Price up from our
previous €8.3. This is based on a 1.1x P/allocated capital and 8.4% COE.
€9.1 Target Price on 2016E... Table 13 shows the rollover to 2016E of our valuation on UCG. The Target Price (TP) raises to €9.1 from €8.3 from a material. We base our valuation on a sum of the parts valuation according to the following methodology:
1) We redistribute the minorities, corporate centre and PPA on the estimated PBT of each
component of UCG;
2) We generate the allocated capital by allocating target CET1 ratio to the individual RWAs;
3) We assign an over the cycle ROAC to each component of UCG by taking as reference the
one estimate for 2016E and adjusting it for the cycle and for case specific items;
4) We estimate the individual COE as per Table 14 and then derive the value of each division
by multiplying the allocated capital by the P/TBV derived;
5) We add the estimated excess capital as the B3FL CET1 ratio minus the allocated capital.
Table 13: UCG 2016E sum of the parts valuation
2016E PBT
MB adj.
net profit RWAs
MB capital
/RWA
Allocated
capital (MB) ROAC
Over the
cycle
ROAC
Cost
of K
P/
TBV Value excess K TP
COMMERCIAL BANKING 4,523 2,625 140,612 9.5% 13,358 19.7% 19.8% 7.3% 2.7x 34,279
...ITALY 4,010 2,328 81,130 9.5% 7,707 30.2% 30.0% 7.9% 3.8x 29,121
...GERMANY 530 307 35,078 9.5% 3,332 9.2% 10.0% 6.5% 1.5x 5,158
...AUSTRIA -18 -10 24,405 9.5% 2,318 -0.4% 0.0% 6.4% .x 0
POLAND 891 517 28,196 9.5% 2,679 19.3% 20.0% 8.4% 2.4x 6,389
CIB 1,948 1,131 69,596 10.0% 6,960 16.2% 16.0% 8.6% 1.9x 12,948
ASSET GATHERING 267 155 1,845 3.0% 55 280.5% 300.0% 6.8% 44.x 2,436
ASSET MANAGEMENT 512 297 2,251 30.0% 311 95.5% 90.0% 6.8% 13.2x 4,113
CEE DIVISION 1,755 1,019 93,701 12.6% 11,853 8.6% 11.2% 9.9% 1.1x 13,732
CEE BOSNIA 53 31 2,221 13.0% 289 10.7% 10.0% 13.3% .8x 218
CEE BULGARIA 208 121 5,535 13.0% 720 16.8% 18.0% 8.6% 2.1x 1,515
CEE CROATIA 179 104 8,332 13.0% 1,083 9.6% 10.0% 8.6% 1.2x 1,267
CEE CZECH 233 135 12,447 11.0% 1,369 9.9% 12.0% 6.7% 1.8x 2,467
CEE HUNGARY 155 90 3,965 11.0% 436 20.6% 20.0% 9.7% 2.1x 898
CEE ROMANIA 71 41 4,870 13.0% 633 6.6% 8.0% 9.7% .8x 524
CEE RUSSIA 469 272 16,734 13.0% 2,175 12.5% 15.0% 11.4% 1.3x 2,867
CEE SERBIA 56 33 2,631 13.0% 342 9.6% 10.0% 13.2% .8x 259
CEE SLOVENIA 29 17 1,336 13.0% 174 9.8% 10.0% 7.2% 1.4x 241
CEE REST OF DIVISION 300 174 35,630 13.0% 4,632 3.8% 8.0% 10.7% .8x 3,476
CORPORATE CENTRE -2,626 0 53,599 10.0% 5,360 0.0% 0.0% 0.0%
CORE 7,270 5,744 389,800 10.4% 40,576 14.2% 0.0% 0.0%
NON-CORE -1,774 -1,774 23,813 10.0% 2,381 -74.5% -75.0% 8.6%
UNICREDIT GROUP 5,496 3,970 413,612 10.4% 42,957 9.2% 10.8% 8.4% 1.1x 53,130 1,714 9.1
Source: Mediobanca Securities
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 33
Price: € 6.26 Target price: € 9.10 Outperform
Table 14: UCG cost of equity estimate
Risk free
rate
RWAs -
Retail
RWAs -
Corporate
Market
premium Beta
Cost of
capital
COMMERCIAL BANKING 1.3% 55.9% 44.1% 5.5% 1.09x 7.3%
...ITALY 2.0% 60.0% 40.0% 5.5% 1.08x 7.9%
...GERMANY 0.3% 40.0% 60.0% 5.5% 1.12x 6.5%
...AUSTRIA 0.5% 65.0% 35.0% 5.5% 1.07x 6.4%
POLAND 2.5% 65.0% 35.0% 5.5% 1.07x 8.4%
CIB 2.0% 0.0% 100.0% 5.5% 1.2x 8.6%
ASSET GATHERING 1.3% 100.0% 0.0% 5.5% 1.x 6.8%
ASSET MANAGEMENT 1.3% 100.0% 0.0% 5.5% 1.x 6.8%
CEE DIVISION 3.7% 37.2% 62.8% 5.5% 1.13x 9.9%
CEE BOSNIA 7.0% 30.0% 70.0% 5.5% 1.14x 13.3%
CEE BULGARIA 2.5% 50.0% 50.0% 5.5% 1.1x 8.6%
CEE CROATIA 2.5% 50.0% 50.0% 5.5% 1.1x 8.6%
CEE CZECH 0.5% 40.0% 60.0% 5.5% 1.12x 6.7%
CEE HUNGARY 3.5% 35.0% 65.0% 5.5% 1.13x 9.7%
CEE ROMANIA 3.5% 40.0% 60.0% 5.5% 1.12x 9.7%
CEE RUSSIA 5.0% 20.0% 80.0% 5.5% 1.16x 11.4%
CEE SERBIA 7.0% 35.0% 65.0% 5.5% 1.13x 13.2%
CEE SLOVENIA 1.0% 35.0% 65.0% 5.5% 1.13x 7.2%
CEE REST OF DIVISION 4.5% 40.0% 60.0% 5.5% 1.12x 10.7%
CORPORATE CENTRE 2.0% 0.0% 100.0% 5.5% 1.2x 8.6%
NON-CORE 2.0% 0.0% 100.0% 5.5% 1.2x 8.6%
UNICREDIT GROUP 2.2% 32.9% 67.1% 5.5% 1.1x 8.4%
Source: Mediobanca Securities, company data
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 34
Price: € 6.26 Target price: € 9.10 Outperform
GENERAL DISCLOSURES
This research report is prepared by Mediobanca - Banca di credito finanziario S.p.A. (“Mediobanca S.p.A.”), authorized and supervised by Bank of Italy and Consob to provide financial services, and is compliant with the relevant European Directive provisions on investment and ancillary services (MiFID Directive) and with the implementing law.
Unless specified to the contrary, within EU Member States, the report is made available by Mediobanca S.p.A. The distribution of this document by Mediobanca S.p.A. in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. All reports are disseminated and available to all clients simultaneously through electronic distribution and publication to our internal client websites. The recipient acknowledges that, to the extent permitted by applicable securities laws and regulations, Mediobanca S.p.A. disclaims all liability for providing this research, and accepts no liability whatsoever for any direct, indirect or consequential loss arising from the use of this document or its contents. This research report is provided for information purposes only and does not constitute or should not be construed as a provision of investment advice, an offer to buy or sell, or a solicitation of an offer to buy or sell, any financial instruments. It is not intended to represent the conclusive terms and conditions of any security or transaction, nor to notify you of any possible risks, direct or indirect, in undertaking such a transaction. Not all investment strategies are appropriate at all times, and past performance is not necessarily a guide to future performance. Mediobanca S.p.A. recommends that independent advice should be sought, and that investors should make their own independent decisions as to whether an investment or instrument is proper or appropriate based on their own individual judgment, their risk-tolerance, and after consulting their own investment advisers. Unless you notify Mediobanca S.p.A. otherwise, Mediobanca S.p.A. assumes that you have sufficient knowledge, experience and/or professional advice to undertake your own assessment. This research is intended for use only by those professional clients to whom it is made available by Mediobanca S.p.A. The information contained herein, including any expression of opinion, has been obtained from or is based upon sources believed to be reliable but is not guaranteed as to accuracy or completeness although Mediobanca S.p.A. considers it to be fair and not misleading. Any opinions or estimates expressed herein reflect the judgment of the author(s) as of the date the research was prepared and are subject to change at any time without notice. Unless otherwise stated, the information or opinions presented, or the research or analysis upon which they are based, are updated as necessary and at least annually. Mediobanca S.p.A. may provide hyperlinks to websites of entities mentioned in this document, however the inclusion of a link does not imply that Mediobanca S.p.A. endorses, recommends or approves any material on the linked page or accessible from it. Mediobanca S.p.A. does not accept responsibility whatsoever for any such material, nor for any consequences of its use. Neither Mediobanca S.p.A. nor any of its directors, officers, employees or agents shall have any liability, howsoever arising, for any error, inaccuracy or incompleteness of fact or opinion in this report or lack of care in its preparation or publication.
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and our proprietary trading desks that reflect opinions that are contrary to the opinions expressed in this research. Our proprietary trading desks and investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research. The analysts named in this report may have from time to time discussed with our clients, including Mediobanca S.p.A. salespersons and traders, or may discuss in this report, trading strategies that reference catalysts or events that may have a near-term impact on the market price of the equity securities discussed in this report, which impact may be directionally counter to the analysts' published price target expectations for such stocks. Any such trading strategies are distinct from and do not affect the analysts' fundamental equity rating for such stocks, which rating reflects a stock's return potential relative to its coverage group as described herein.
ADDITIONAL DISCLAIMERS TO U.S. INVESTORS: This research report is prepared by Mediobanca S.p.A. and distributed in the United States by Mediobanca Securities USA LLC, which is a wholly owned subsidiary of Mediobanca S.p.A., is a member of Finra and is registered with the US Securities and Exchange Commission. 565 Fifth Avenue - New York NY 10017. Mediobanca Securities USA LLC accepts responsibility for the content of this report. Any US person receiving this report and wishing to effect any transaction in any security discussed in this report should contact Mediobanca Securities USA LLC at 001(212) 991-4745. Please refer to the contact page for additional contact information. All transactions by a US person in the securities mentioned in this report must be effected through Mediobanca Securities USA LLC and not through a non-US affiliate. The research analyst(s) named on this report are not registered / qualified as research analysts with Finra. The research analyst(s) are not associated persons of Mediobanca Securities USA LLC and therefore are not subject to NASD rule 2711 and incorporated NYSE rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst.
ADDITIONAL DISCLAIMERS TO U.K. INVESTORS: Mediobanca S.p.A. provides investment services in the UK through a branch established in the UK (as well as directly from its establishment(s) in Italy) pursuant to its passporting rights under applicable EEA Banking and Financial Services Directives and in accordance with applicable Financial Services Authority requirements.
ADDITIONAL DISCLAIMERS TO U.A.E. INVESTORS: This research report has not been approved or licensed by the UAE Central Bank, the UAE Securities and Commodities Authority (SCA), the Dubai Financial Services Authority (DFSA) or any other relevant licensing authorities in the UAE, and does not constitute a public offer of securities in the UAE in accordance with the commercial companies law, Federal Law No. 8 of 1984 (as amended), SCA Resolution No.(37) of 2012 or otherwise. This research report is strictly private and confidential and is being issued to sophisticated investors.
REGULATORY DISCLOSURES
Mediobanca S.p.A. does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Mediobanca S.p.A. or its affiliates or its employees may effect transactions in the securities described herein for their own account or for the account of others, may have long or short positions with the issuer thereof, or any of its affiliates, or may perform or seek to perform securities, investment banking or other services for such issuer or its affiliates. The organisational and administrative arrangements established by Mediobanca S.p.A. for the management of conflicts of interest with respect to investment research are consistent with rules, regulations or codes applicable to the securities industry. The compensation of the analyst who prepared this report is determined exclusively by research management and senior
Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 35
Price: € 6.26 Target price: € 9.10 Outperform
management (not including investment banking). Analyst compensation is not based on investment banking revenues, however, compensation may relate to the revenues of Mediobanca S.p.A. as a whole, of which investment banking, sales and trading are a part.
For a detailed explanation of the policies and principles implemented by Mediobanca S.p.A. to guarantee the integrity and independence of researches prepared by Mediobanca's analysts, please refer to the research policy which can be found at the following link: http://www.mediobanca.it/static/upload/b5d/b5d01c423f1f84fffea37bd41ccf7d74.pdf
Unless otherwise stated in the text of the research report, target prices are based on either a discounted cash flow valuation and/or comparison of valuation ratios with companies seen by the analyst as comparable or a combination of the two methods. The result of this fundamental valuation is adjusted to reflect the analyst's views on the likely course of investor sentiment. Whichever valuation method is used there is a significant risk that the target price will not be achieved within the expected timeframe. Risk factors include unforeseen changes in competitive pressures or in the level of demand for the company's products. Such demand variations may result from changes in technology, in the overall level of economic activity or, in some cases, from changes in social values. Valuations may also be affected by changes in taxation, in exchange rates and, in certain industries, in regulations. All prices are market close prices unless differently specified.
Since 1 July 2013, Mediobanca uses a relative rating system, based on the following judgements: Outperform, Neutral, Underperform and Not Rated.
Outperform (O). The stock‟s total return is expected to exceed the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Neutral (N). The stock‟s total return is expected to be in line with the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Underperform (U). The stock‟s total return is expected to be below the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Not Rated (NR). Currently the analyst does not have adequate confidence about the stock‟s total return relative to the average total return of the analyst‟s industry (or industry team‟s) coverage, on a risk-adjusted basis, over the next 6-12 months. Alternatively, it is applicable pursuant to Mediobanca policy in circumstances when Mediobanca is acting in any advisory capacity in a strategic transaction involving this company or when the company is the target of a tender offer.
Our recommendation relies upon the expected relative performance of the stock considered versus its benchmark. Such an expected relative performance relies upon a valuation process that is based on the analysis of the company's business model / competitive positioning / financial forecasts. The company's valuation could change in the future as a consequence of a modification of the mentioned items.
Please consider that the above rating system also drives the portfolio selections of the Mediobanca's analysts as follows: long positions can only apply to stocks rated Outperform and Neutral; short positions can only apply to stocks rated Underperform and Neutral; portfolios selection cannot refer to Not Rated stocks; Mediobanca portfolios might follow different time horizons.
Proportion of all recommendations relating to the last quarter
Outperform Neutral Underperform Not Rated
53.07% 39.39% 6.70% 0.84%
Proportion of issuers to which Mediobanca S.p.A. has supplied material investment banking services relating to the last quarter:
Outperform Neutral Underperform Not Rated
12.31% 13.79% 10.00% 100.00%
The current stock ratings system has been used since 1 July 2013. Before then, Mediobanca S.p.A. used a different system, based on the following ratings: outperform, neutral, underperform, under review, not rated. For additional details about the old ratings system, please access research reports dated before 1 July 2013 from the restricted part of the “MB Securities” section of the Mediobanca S.p.A. website at www.mediobanca.com.
Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 36
Price: € 6.26 Target price: € 9.10 Outperform
COMPANY SPECIFIC REGULATORY DISCLOSURES
MARKET MAKER Mediobanca S.p.A. is currently acting as market maker on equity instruments, or derivatives whose underlying financial instruments are materially represented by equity instruments, issued by Unicredit. MEDIOBANCA SIGNIFICANT FINANCIAL INTERESTS As of the date of publication of this research report, Mediobanca Securities USA LLC's parent company, Mediobanca S.p.A. beneficially owns 1% or more of any class of common equity securities of the securities of Unicredit. ISSUER REPRESENTATION ON MEDIOBANCA GOVERNING BODIES Certain members of the governing bodies of Unicredit are also members of the governing bodies of Mediobanca S.p.A. or one or more of the companies belonging to its group. ISSUER SIGNIFICANT FINANCIAL INTERESTS ON MEDIOBANCA Unicredit owns a “major holding” (as defined in the EU Transparency Directive as implemented in each relevant jurisdiction) in Mediobanca S.p.A. Please consult the website of the relevant competent authority for details.
RATING The present rating in regard to Unicredit has not been changed since 26/03/2012.
INITIAL COVERAGE
Unicredit initial coverage as of 30/06/2003.
COPYRIGHT NOTICE
No part of the content of any research material may be copied, forwarded or duplicated in any form or by any means without the prior consent of Mediobanca S.p.A., and Mediobanca S.p.A. accepts no liability whatsoever for the actions of third parties in this respect. END NOTES
The disclosures contained in research reports produced by Mediobanca S.p.A. shall be governed by and construed in accordance with Italian law. Additional information is available upon request.
Disclaimer Disclaimer Disclaimer Disclaimer Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 37
Price: € 6.26 Target price: € 9.10 Outperform
Mediobanca S.p.A. Antonio Guglielmi
Head of European Equity Research +44 203 0369 570
[email protected] ANALYSTS
European Banks
Alain Tchibozo France/IBK +44 203 0369 573 [email protected]
Adam Terelak France/IBK +44 203 0369 574 [email protected]
Andrea Filtri Spain/Italy +44 203 0369 571 [email protected]
Andres Williams Spain +44 203 0369 577 [email protected]
Riccardo Rovere Italy/Scandinavia/CEE/Germany +39 02 8829 604 [email protected]
European Insurance
Gianluca Ferrari Italy and Reinsurance +39 02 8829 482 [email protected]
Simonetta Chiriotti Nordics +39 02 8829 933 [email protected]
Italian Research
Alessandro Tortora Building Materials/Industrials/Capital Goods +39 02 8829 673 [email protected]
Andrea Scauri Oil & Oil Related/Capital Goods +39 02 8829 496 [email protected]
Chiara Rotelli Branded Goods/Consumers Goods +39 02 8829 931 [email protected]
Fabio Pavan Media/Telecommunications/Consumer Goods +39 02 8829 633 [email protected]
Javier Suárez Utilities +39 028829 036 [email protected]
Jean Farah Utilities +44 203 0369 665 [email protected] Massimo Vecchio Auto & Auto Components/Industrials/Holdings +39 02 8829 541 [email protected]
Niccolò Storer Auto & Auto Components/Industrials/Holdings +39 02 8829 444 [email protected]
Nicolò Pessina Consumer Goods/Infrastructure +39 02 8829 796 [email protected]
Sara Piccinini Utilities +39 02 8829 295 [email protected] Simonetta Chiriotti Real Estate/ Industrials +39 02 8829 933 [email protected]
FOR NON US PERSON receiving this document and wishing to effect transactions in any securities discussed herein, please contact:
Mediobanca S.p.A. Charlotte Roden
Head of Equity Sales +44 203 0369 537
[email protected] SALES
Angelo Vietri
+39 02 8829 989 [email protected]
Christopher Seidenfaden
+44 203 0369 610 [email protected]
Lorenzo Angeloni
+39 02 8829 507 [email protected]
Timothy Pedroni
+44 203 0369 635 [email protected]
Stephane Langlois
+44 203 0369 582 [email protected]
European Spec Sales
Gaelle Jarrousse Banks +44 203 0369 530 [email protected]
Carlo Pirri Banks +44 203 0369 531 [email protected]
Gert-Jaap Kraan Insurance +44 203 0369 510 [email protected]
Mediobanca S.p.A. Dominic Bidwell
Head of Equity Trading and Sales Trading +44 203 0369 627
[email protected] SALES/TRADERS
Alessandro Gobbi
+39 02 8829 263 [email protected]
Matteo Agrati
+44 203 0369 629 [email protected]
Michael Sherry
+44 203 0369 605 [email protected]
Roberto Riboldi +39 02 8829 639 [email protected]
FOR US PERSON receiving this document and wishing to effect transactions in any securities discussed herein, please contact:
Mediobanca Securities USA LLC Pierluigi Gastone
Head of Mediobanca Securities USA LLC +1 212 991 4745
Massimiliano Pula
+1 646 839 4911 [email protected]
Robert Perez
+1 646 839 4910 [email protected]
MEDIOBANCA – Banca di Credito Finanziario S.p.A. Piazzetta Enrico Cuccia, 1 - 20121 Milano - T. +39 02 8829.1 33 Grosvenor Place – London SW1X 7HY – T. +44 (0) 203 0369 530
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 38
Price: € 6.26 Target price: € 9.10 Outperform
GENERAL DISCLOSURES
This research report is prepared by Mediobanca - Banca di credito finanziario S.p.A. (“Mediobanca S.p.A.”), authorized and supervised by Bank of Italy and Consob to provide financial services, and is compliant with the relevant European Directive provisions on investment and ancillary services (MiFID Directive) and with the implementing law.
Unless specified to the contrary, within EU Member States, the report is made available by Mediobanca S.p.A. The distribution of this document by Mediobanca S.p.A. in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. All reports are disseminated and available to all clients simultaneously through electronic distribution and publication to our internal client websites. The recipient acknowledges that, to the extent permitted by applicable securities laws and regulations, Mediobanca S.p.A. disclaims all liability for providing this research, and accepts no liability whatsoever for any direct, indirect or consequential loss arising from the use of this document or its contents. This research report is provided for information purposes only and does not constitute or should not be construed as a provision of investment advice, an offer to buy or sell, or a solicitation of an offer to buy or sell, any financial instruments. It is not intended to represent the conclusive terms and conditions of any security or transaction, nor to notify you of any possible risks, direct or indirect, in undertaking such a transaction. Not all investment strategies are appropriate at all times, and past performance is not necessarily a guide to future performance. Mediobanca S.p.A. recommends that independent advice should be sought, and that investors should make their own independent decisions as to whether an investment or instrument is proper or appropriate based on their own individual judgment, their risk-tolerance, and after consulting their own investment advisers. Unless you notify Mediobanca S.p.A. otherwise, Mediobanca S.p.A. assumes that you have sufficient knowledge, experience and/or professional advice to undertake your own assessment. This research is intended for use only by those professional clients to whom it is made available by Mediobanca S.p.A. The information contained herein, including any expression of opinion, has been obtained from or is based upon sources believed to be reliable but is not guaranteed as to accuracy or completeness although Mediobanca S.p.A. considers it to be fair and not misleading. Any opinions or estimates expressed herein reflect the judgment of the author(s) as of the date the research was prepared and are subject to change at any time without notice. Unless otherwise stated, the information or opinions presented, or the research or analysis upon which they are based, are updated as necessary and at least annually. Mediobanca S.p.A. may provide hyperlinks to websites of entities mentioned in this document, however the inclusion of a link does not imply that Mediobanca S.p.A. endorses, recommends or approves any material on the linked page or accessible from it. Mediobanca S.p.A. does not accept responsibility whatsoever for any such material, nor for any consequences of its use. Neither Mediobanca S.p.A. nor any of its directors, officers, employees or agents shall have any liability, howsoever arising, for any error, inaccuracy or incompleteness of fact or opinion in this report or lack of care in its preparation or publication.
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and our proprietary trading desks that reflect opinions that are contrary to the opinions expressed in this research. Our proprietary trading desks and investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research. The analysts named in this report may have from time to time discussed with our clients, including Mediobanca S.p.A. salespersons and traders, or may discuss in this report, trading strategies that reference catalysts or events that may have a near-term impact on the market price of the equity securities discussed in this report, which impact may be directionally counter to the analysts' published price target expectations for such stocks. Any such trading strategies are distinct from and do not affect the analysts' fundamental equity rating for such stocks, which rating reflects a stock's return potential relative to its coverage group as described herein.
ADDITIONAL DISCLAIMERS TO U.S. INVESTORS: This research report is prepared by Mediobanca S.p.A. and distributed in the United States by Mediobanca Securities USA LLC, which is a wholly owned subsidiary of Mediobanca S.p.A., is a member of Finra and is registered with the US Securities and Exchange Commission. 565 Fifth Avenue - New York NY 10017. Mediobanca Securities USA LLC accepts responsibility for the content of this report. Any US person receiving this report and wishing to effect any transaction in any security discussed in this report should contact Mediobanca Securities USA LLC at 001(212) 991-4745. Please refer to the contact page for additional contact information. All transactions by a US person in the securities mentioned in this report must be effected through Mediobanca Securities USA LLC and not through a non-US affiliate. The research analyst(s) named on this report are not registered / qualified as research analysts with Finra. The research analyst(s) are not associated persons of Mediobanca Securities USA LLC and therefore are not subject to NASD rule 2711 and incorporated NYSE rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst.
ADDITIONAL DISCLAIMERS TO U.K. INVESTORS: Mediobanca S.p.A. provides investment services in the UK through a branch established in the UK (as well as directly from its establishment(s) in Italy) pursuant to its passporting rights under applicable EEA Banking and Financial Services Directives and in accordance with applicable Financial Services Authority requirements.
ADDITIONAL DISCLAIMERS TO U.A.E. INVESTORS: This research report has not been approved or licensed by the UAE Central Bank, the UAE Securities and Commodities Authority (SCA), the Dubai Financial Services Authority (DFSA) or any other relevant licensing authorities in the UAE, and does not constitute a public offer of securities in the UAE in accordance with the commercial companies law, Federal Law No. 8 of 1984 (as amended), SCA Resolution No.(37) of 2012 or otherwise. This research report is strictly private and confidential and is being issued to sophisticated investors.
REGULATORY DISCLOSURES
Mediobanca S.p.A. does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Mediobanca S.p.A. or its affiliates or its employees may effect transactions in the securities described herein for their own account or for the account of others, may have long or short positions with the issuer thereof, or any of its affiliates, or may perform or seek to perform securities, investment banking or other services for such issuer or its affiliates. The organisational and administrative arrangements established by Mediobanca S.p.A. for the management of conflicts of interest with respect to investment research are consistent with rules, regulations or codes applicable to the securities industry. The compensation of the analyst who prepared this report is determined exclusively by research management and senior
Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 39
Price: € 6.26 Target price: € 9.10 Outperform
management (not including investment banking). Analyst compensation is not based on investment banking revenues, however, compensation may relate to the revenues of Mediobanca S.p.A. as a whole, of which investment banking, sales and trading are a part.
For a detailed explanation of the policies and principles implemented by Mediobanca S.p.A. to guarantee the integrity and independence of researches prepared by Mediobanca's analysts, please refer to the research policy which can be found at the following link: http://www.mediobanca.it/static/upload/b5d/b5d01c423f1f84fffea37bd41ccf7d74.pdf
Unless otherwise stated in the text of the research report, target prices are based on either a discounted cash flow valuation and/or comparison of valuation ratios with companies seen by the analyst as comparable or a combination of the two methods. The result of this fundamental valuation is adjusted to reflect the analyst's views on the likely course of investor sentiment. Whichever valuation method is used there is a significant risk that the target price will not be achieved within the expected timeframe. Risk factors include unforeseen changes in competitive pressures or in the level of demand for the company's products. Such demand variations may result from changes in technology, in the overall level of economic activity or, in some cases, from changes in social values. Valuations may also be affected by changes in taxation, in exchange rates and, in certain industries, in regulations. All prices are market close prices unless differently specified.
Since 1 July 2013, Mediobanca uses a relative rating system, based on the following judgements: Outperform, Neutral, Underperform and Not Rated.
Outperform (O). The stock‟s total return is expected to exceed the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Neutral (N). The stock‟s total return is expected to be in line with the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Underperform (U). The stock‟s total return is expected to be below the average total return of the analyst‟s industry (or industry team‟s) coverage universe, on a risk-adjusted basis, over the next 6-12 months.
Not Rated (NR). Currently the analyst does not have adequate confidence about the stock‟s total return relative to the average total return of the analyst‟s industry (or industry team‟s) coverage, on a risk-adjusted basis, over the next 6-12 months. Alternatively, it is applicable pursuant to Mediobanca policy in circumstances when Mediobanca is acting in any advisory capacity in a strategic transaction involving this company or when the company is the target of a tender offer.
Our recommendation relies upon the expected relative performance of the stock considered versus its benchmark. Such an expected relative performance relies upon a valuation process that is based on the analysis of the company's business model / competitive positioning / financial forecasts. The company's valuation could change in the future as a consequence of a modification of the mentioned items.
Please consider that the above rating system also drives the portfolio selections of the Mediobanca's analysts as follows: long positions can only apply to stocks rated Outperform and Neutral; short positions can only apply to stocks rated Underperform and Neutral; portfolios selection cannot refer to Not Rated stocks; Mediobanca portfolios might follow different time horizons.
Proportion of all recommendations relating to the last quarter
Outperform Neutral Underperform Not Rated
53.07% 39.39% 6.70% 0.84%
Proportion of issuers to which Mediobanca S.p.A. has supplied material investment banking services relating to the last quarter:
Outperform Neutral Underperform Not Rated
12.31% 13.79% 10.00% 100.00%
The current stock ratings system has been used since 1 July 2013. Before then, Mediobanca S.p.A. used a different system, based on the following ratings: outperform, neutral, underperform, under review, not rated. For additional details about the old ratings system, please access research reports dated before 1 July 2013 from the restricted part of the “MB Securities” section of the Mediobanca S.p.A. website at www.mediobanca.com.
Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 40
Price: € 6.26 Target price: € 9.10 Outperform
COMPANY SPECIFIC REGULATORY DISCLOSURES
MARKET MAKER Mediobanca S.p.A. is currently acting as market maker on equity instruments, or derivatives whose underlying financial instruments are materially represented by equity instruments, issued by Unicredit. MEDIOBANCA SIGNIFICANT FINANCIAL INTERESTS As of the date of publication of this research report, Mediobanca Securities USA LLC's parent company, Mediobanca S.p.A. beneficially owns 1% or more of any class of common equity securities of the securities of Unicredit. ISSUER REPRESENTATION ON MEDIOBANCA GOVERNING BODIES Certain members of the governing bodies of Unicredit are also members of the governing bodies of Mediobanca S.p.A. or one or more of the companies belonging to its group. ISSUER SIGNIFICANT FINANCIAL INTERESTS ON MEDIOBANCA Unicredit owns a “major holding” (as defined in the EU Transparency Directive as implemented in each relevant jurisdiction) in Mediobanca S.p.A. Please consult the website of the relevant competent authority for details.
RATING The present rating in regard to Unicredit has not been changed since 26/03/2012.
INITIAL COVERAGE
Unicredit initial coverage as of 30/06/2003.
COPYRIGHT NOTICE
No part of the content of any research material may be copied, forwarded or duplicated in any form or by any means without the prior consent of Mediobanca S.p.A., and Mediobanca S.p.A. accepts no liability whatsoever for the actions of third parties in this respect. END NOTES
The disclosures contained in research reports produced by Mediobanca S.p.A. shall be governed by and construed in accordance with Italian law. Additional information is available upon request.
Disclaimer Disclaimer Disclaimer Disclaimer Disclaimer
Un
auth
ori
zed
red
istr
ibu
tio
n o
f th
is r
epo
rt is
pro
hib
ited
.T
his
rep
ort
is in
ten
ded
fo
r A
nd
rea.
Filt
ri@
med
iob
anca
.co
m f
rom
MB
.An
dre
a.F
iltri
@m
edio
ban
ca.c
om
Unicredit
07 May 2015 ◆ 41
Price: € 6.26 Target price: € 9.10 Outperform
Mediobanca S.p.A. Antonio Guglielmi
Head of European Equity Research +44 203 0369 570
[email protected] ANALYSTS
European Banks
Alain Tchibozo France/IBK +44 203 0369 573 [email protected]
Adam Terelak France/IBK +44 203 0369 574 [email protected]
Andrea Filtri Spain/Italy +44 203 0369 571 [email protected]
Andres Williams Spain +44 203 0369 577 [email protected]
Riccardo Rovere Italy/Scandinavia/CEE/Germany +39 02 8829 604 [email protected]
European Insurance
Gianluca Ferrari Italy and Reinsurance +39 02 8829 482 [email protected]
Simonetta Chiriotti Nordics +39 02 8829 933 [email protected]
Italian Research
Alessandro Tortora Building Materials/Industrials/Capital Goods +39 02 8829 673 [email protected]
Andrea Scauri Oil & Oil Related/Capital Goods +39 02 8829 496 [email protected]
Chiara Rotelli Branded Goods/Consumers Goods +39 02 8829 931 [email protected]
Fabio Pavan Media/Telecommunications/Consumer Goods +39 02 8829 633 [email protected]
Javier Suárez Utilities +39 028829 036 [email protected]
Jean Farah Utilities +44 203 0369 665 [email protected] Massimo Vecchio Auto & Auto Components/Industrials/Holdings +39 02 8829 541 [email protected]
Niccolò Storer Auto & Auto Components/Industrials/Holdings +39 02 8829 444 [email protected]
Nicolò Pessina Consumer Goods/Infrastructure +39 02 8829 796 [email protected]
Sara Piccinini Utilities +39 02 8829 295 [email protected] Simonetta Chiriotti Real Estate/ Industrials +39 02 8829 933 [email protected]
FOR NON US PERSON receiving this document and wishing to effect transactions in any securities discussed herein, please contact:
Mediobanca S.p.A. Charlotte Roden
Head of Equity Sales +44 203 0369 537
[email protected] SALES
Angelo Vietri
+39 02 8829 989 [email protected]
Christopher Seidenfaden
+44 203 0369 610 [email protected]
Lorenzo Angeloni
+39 02 8829 507 [email protected]
Timothy Pedroni
+44 203 0369 635 [email protected]
Stephane Langlois
+44 203 0369 582 [email protected]
European Spec Sales
Gaelle Jarrousse Banks +44 203 0369 530 [email protected]
Carlo Pirri Banks +44 203 0369 531 [email protected]
Gert-Jaap Kraan Insurance +44 203 0369 510 [email protected]
Mediobanca S.p.A. Dominic Bidwell
Head of Equity Trading and Sales Trading +44 203 0369 627
[email protected] SALES/TRADERS
Alessandro Gobbi
+39 02 8829 263 [email protected]
Matteo Agrati
+44 203 0369 629 [email protected]
Michael Sherry
+44 203 0369 605 [email protected]
Roberto Riboldi +39 02 8829 639 [email protected]
FOR US PERSON receiving this document and wishing to effect transactions in any securities discussed herein, please contact:
Mediobanca Securities USA LLC Pierluigi Gastone
Head of Mediobanca Securities USA LLC +1 212 991 4745
Massimiliano Pula
+1 646 839 4911 [email protected]
Robert Perez
+1 646 839 4910 [email protected]
MEDIOBANCA – Banca di Credito Finanziario S.p.A. Piazzetta Enrico Cuccia, 1 - 20121 Milano - T. +39 02 8829.1 33 Grosvenor Place – London SW1X 7HY – T. +44 (0) 203 0369 530